• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极早产儿应用神经调节辅助通气或同步间歇正压通气时的人机同步性:一项随机交叉先导试验。

Patient-Ventilator Synchrony in Extremely Premature Neonates during Non-Invasive Neurally Adjusted Ventilatory Assist or Synchronized Intermittent Positive Airway Pressure: A Randomized Crossover Pilot Trial.

机构信息

Neonatal Intensive Care Unit, CHI Créteil, Créteil, France.

INSERM, CNRS ERL 7000, IMRB, Université Paris Est Creteil, Créteil, France.

出版信息

Neonatology. 2022;119(3):386-393. doi: 10.1159/000524327. Epub 2022 May 3.

DOI:10.1159/000524327
PMID:35504256
Abstract

INTRODUCTION

Synchronization of non-invasive ventilation is challenging in extremely premature infants. We compared patient-ventilator synchrony between non-invasive neurally adjusted ventilatory assist (NIV-NAVA) using transdiaphragmatic (Edi) catheter and synchronized intermittent positive airway pressure (SiPAP) using an abdominal trigger.

METHODS

This study was a monocentric, randomized, crossover trial in premature infants born before 28 weeks of gestation, aged 3 days or more, and below 32 weeks postmenstrual age. NIV-NAVA and SiPAP were applied in a random order for 2 h with analysis of data from the second hour. The primary outcome was the asynchrony index.

RESULTS

Fourteen patients were included (median [IQR] gestational age at birth 25.6 (25.3-26.4) weeks, median [IQR] birth weight 755 [680-824] g, median [IQR] postnatal age 26.5 [19.8-33.8] days). The median (IQR) asynchrony index was significantly lower in NIV-NAVA versus SiPAP (49.9% [44.1-52.6] vs. 85.8% [74.2-90.9], p < 0.001). Ineffective efforts and auto-triggering were significantly less frequent in NIV-NAVA versus SiPAP (3.0% vs. 32.0% p < 0.001 and 10.0% vs. 26.6%, p = 0.004, respectively). Double triggering was significantly less frequent in SiPAP versus NIV-NAVA (0.0% vs. 9.0%, p < 0.001). No significant difference was observed for premature cycling and late cycling. Peak Edi and swing Edi were significantly lower in NIV-NAVA as compared to SiPAP (7.7 [6.1-9.9] vs. 11.0 [6.7-14.5] μV, p = 0.006; 5.4 [4.2-7.6] vs. 7.6 [4.3-10.8] μV, p = 0.007, respectively). No significant difference was observed between NIV-NAVA and SiPAP for heart rate, respiratory rate, COMFORTneo scores, apnoea, desaturations, or bradycardias.

DISCUSSION/CONCLUSION: NIV-NAVA markedly improves patient-ventilator synchrony as compared to SiPAP in extremely premature infants.

摘要

简介

在极早产儿中,无创通气的同步性具有挑战性。我们比较了经膈肌(Edi)导管的神经调节辅助无创通气(NIV-NAVA)和腹部触发的同步间歇正压通气(SiPAP)之间的患者-呼吸机同步性。

方法

这是一项单中心、随机、交叉试验,纳入了胎龄 28 周以下、3 天或以上、孕龄 32 周以下的早产儿。以随机顺序应用 NIV-NAVA 和 SiPAP 各 2 小时,分析第 2 小时的数据。主要结局是失同步指数。

结果

共纳入 14 名患者(中位[IQR]出生时胎龄 25.6[25.3-26.4]周,中位[IQR]出生体重 755[680-824]g,中位[IQR]生后年龄 26.5[19.8-33.8]天)。与 SiPAP 相比,NIV-NAVA 的失同步指数明显更低(49.9%[44.1-52.6] vs. 85.8%[74.2-90.9],p<0.001)。与 SiPAP 相比,NIV-NAVA 中无效努力和自动触发的频率明显更低(3.0% vs. 32.0%,p<0.001 和 10.0% vs. 26.6%,p=0.004)。SiPAP 中双触发的频率明显低于 NIV-NAVA(0.0% vs. 9.0%,p<0.001)。在过早触发和延迟触发方面,NIV-NAVA 与 SiPAP 之间无显著差异。与 SiPAP 相比,NIV-NAVA 的峰值 Edi 和摆动 Edi 明显更低(7.7[6.1-9.9] vs. 11.0[6.7-14.5]μV,p=0.006;5.4[4.2-7.6] vs. 7.6[4.3-10.8]μV,p=0.007)。与 SiPAP 相比,NIV-NAVA 对心率、呼吸频率、舒适评分、呼吸暂停、低氧血症或心动过缓无显著影响。

讨论/结论:与 SiPAP 相比,NIV-NAVA 可显著改善极早产儿的患者-呼吸机同步性。

相似文献

1
Patient-Ventilator Synchrony in Extremely Premature Neonates during Non-Invasive Neurally Adjusted Ventilatory Assist or Synchronized Intermittent Positive Airway Pressure: A Randomized Crossover Pilot Trial.极早产儿应用神经调节辅助通气或同步间歇正压通气时的人机同步性:一项随机交叉先导试验。
Neonatology. 2022;119(3):386-393. doi: 10.1159/000524327. Epub 2022 May 3.
2
The Diaphragmatic Initiated Ventilatory Assist (DIVA) trial: study protocol for a randomized controlled trial comparing rates of extubation failure in extremely premature infants undergoing extubation to non-invasive neurally adjusted ventilatory assist versus non-synchronized nasal intermittent positive pressure ventilation.膈肌启动通气辅助(DIVA)试验:一项随机对照试验的研究方案,比较极早产儿拔管后接受非侵入性神经调节通气辅助与非同步鼻塞间歇正压通气的拔管失败率。
Trials. 2024 Mar 20;25(1):201. doi: 10.1186/s13063-024-08038-4.
3
Non-invasive neurally adjusted ventilatory assist in preterm infants: a randomised phase II crossover trial.非侵入性神经调节通气辅助治疗早产儿:一项随机 II 期交叉试验。
Arch Dis Child Fetal Neonatal Ed. 2015 Nov;100(6):F507-13. doi: 10.1136/archdischild-2014-308057. Epub 2015 Jul 15.
4
Improved nutritional outcomes with neurally adjusted ventilatory assist (NAVA) in premature infants: a single tertiary neonatal unit's experience.神经调节辅助通气(NAVA)改善早产儿的营养结局:单中心三级新生儿病房的经验。
Eur J Pediatr. 2022 May;181(5):2155-2159. doi: 10.1007/s00431-022-04411-0. Epub 2022 Feb 22.
5
Cardiorespiratory effects of NIV-NAVA, NIPPV, and NCPAP shortly after extubation in extremely preterm infants: A randomized crossover trial.极早产儿拔管后即刻应用 NIV-NAVA、NIPPV 和 NCPAP 的心肺影响:一项随机交叉试验。
Pediatr Pulmonol. 2021 Oct;56(10):3273-3282. doi: 10.1002/ppul.25607. Epub 2021 Aug 11.
6
Neurally adjusted ventilatory assist (NAVA) allows patient-ventilator synchrony during pediatric noninvasive ventilation: a crossover physiological study.神经调节通气辅助(NAVA)在小儿无创通气期间可实现患者与呼吸机同步:一项交叉生理学研究。
Crit Care. 2015 Feb 17;19(1):44. doi: 10.1186/s13054-015-0770-7.
7
Neurally adjusted ventilator assist (NAVA) reduces asynchrony during non-invasive ventilation for severe bronchiolitis.神经调节通气辅助(NAVA)可减少重度细支气管炎无创通气期间的不同步性。
Pediatr Pulmonol. 2015 Dec;50(12):1320-7. doi: 10.1002/ppul.23139. Epub 2014 Dec 8.
8
Work of Breathing in Premature Neonates: Noninvasive Neurally-Adjusted Ventilatory Assist versus Noninvasive Ventilation.早产儿呼吸做功:神经调节辅助通气与无创通气的比较。
Respir Care. 2020 Jul;65(7):946-953. doi: 10.4187/respcare.07257. Epub 2020 Feb 18.
9
[Study on patient-ventilator synchrony of neurally adjusted ventilatory assist ventilation in severe neurological diseases patients with tracheotomy].[神经调节通气辅助通气在重度神经系统疾病气管切开患者中的患者-呼吸机同步性研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):575-580. doi: 10.3760/cma.j.cn121430-20200427-00341.
10
NIV-NAVA versus NCPAP immediately after birth in premature infants: A randomized controlled trial.经鼻间歇正压通气与持续气道正压通气即刻应用于早产儿出生后的随机对照试验。
Respir Physiol Neurobiol. 2022 Aug;302:103916. doi: 10.1016/j.resp.2022.103916. Epub 2022 Apr 29.

引用本文的文献

1
Efficacy of Noninvasive Neurally Adjusted Ventilatory Assist (NIV-NAVA) for Neonates With Transient Tachypnea of the Newborn: A Retrospective Analysis.无创神经调节通气辅助(NIV-NAVA)对新生儿暂时性呼吸急促的疗效:一项回顾性分析。
Pediatr Pulmonol. 2025 Aug;60(8):e71246. doi: 10.1002/ppul.71246.
2
Non-invasive neurally adjusted ventilatory assist versus nasal continuous positive airway pressure for premature infants: a systematic review and meta-analysis.无创神经调节通气辅助与经鼻持续气道正压通气用于早产儿:一项系统评价和荟萃分析
Eur J Med Res. 2025 Jul 5;30(1):577. doi: 10.1186/s40001-025-02803-0.
3
Effect of neurally adjusted ventilator assist versus pressure support ventilation on asynchronies and cardiac function in pediatric liver transplantation.
神经调节通气辅助与压力支持通气对小儿肝移植中呼吸不同步及心功能的影响
Sci Rep. 2025 Feb 28;15(1):7158. doi: 10.1038/s41598-025-91590-z.
4
NIV-NAVA versus non-invasive respiratory support in preterm neonates: a meta-analysis of randomized controlled trials.NIV-NAVA 与早产儿非侵入性呼吸支持的比较:随机对照试验的荟萃分析。
J Perinatol. 2024 Sep;44(9):1276-1284. doi: 10.1038/s41372-024-01947-x. Epub 2024 Mar 29.
5
Noninvasive Neurally Adjusted Ventilation versus Nasal Continuous or Intermittent Positive Airway Pressure for Preterm Infants: A Systematic Review and Meta-Analysis.无创神经调节通气与经鼻持续或间歇气道正压通气用于早产儿:一项系统评价和荟萃分析
Children (Basel). 2023 Dec 18;10(12):1935. doi: 10.3390/children10121935.
6
Non-invasive ventilation in neonates: a review of current literature.新生儿无创通气:当前文献综述
Front Pediatr. 2023 Nov 28;11:1248836. doi: 10.3389/fped.2023.1248836. eCollection 2023.
7
Monitoring the patient-ventilator asynchrony during non-invasive ventilation.在无创通气期间监测患者-呼吸机不同步情况。
Front Med (Lausanne). 2023 Jan 19;9:1119924. doi: 10.3389/fmed.2022.1119924. eCollection 2022.